FDA Withdraws Emergency Use Authorization For AstraZeneca’s COVID-19 Antibody Cocktail Tixagevimab/Cilgavimab
January 27, 2023
Reuters (1/26, Satija, Mandowara) reports the FDA “has withdrawn emergency-use authorization for AstraZeneca’s COVID-19 antibody cocktail” tixagevimab/cilgavimab (Evusheld) “as the treatment is not expected to neutralize the currently dominant XBB.1.5 sub...